The upcoming report from Xylem (XYL) is expected to reveal quarterly earnings of $0.84 per share, indicating an increase of 16.7% compared to the year-ago period. Analysts forecast revenues of $2 billion, representing an increase of 38.1% year over year. Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 0.1% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period. Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock. While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights. Bearing this in mind, let's now explore the average estimates of specific Xylem metrics that are commonly monitored and projected by Wall Street analysts. The combined assessment of analysts suggests that 'Revenue- Measurement & Control Solutions' will likely reach $474.96 million. The estimate points to a change of +17% from the year-ago quarter. Analysts expect 'Revenue- Applied Water' to come in at $439.40 million. The estimate suggests a change of -3% year over year. The average prediction of analysts places 'Revenue- Water Infrastructure' at $751.35 million. The estimate suggests a change of +27.6% year over year. The consensus estimate for 'Adjusted Operating Income- Water Infrastructure' stands at $108.33 million. The estimate compares to the year-ago value of $73 million. Analysts predict that the 'Adjusted Operating Income- Applied Water' will reach $77.87 million. The estimate is in contrast to the year-ago figure of $86 million. It is projected by analysts that the 'Adjusted Operating Income- Measurement & Control Solutions' will reach $58.84 million. Compared to the current estimate, the company reported $27 million in the same quarter of the previous year. View all Key Company Metrics for Xylem here>>> Over the past month, Xylem shares have recorded returns of +2.5% versus the Zacks S&P 500 composite's -2% change. Based on its Zacks Rank #3 (Hold), XYL will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Xylem Inc. (XYL):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Xylem (XYL) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...